Atlas Trials

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

Clinical trial NCT00522392 · TERMINATED

Trial details

NCT number
NCT00522392
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Start date
2007-09-01
Primary completion
2012-08-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.